Anti-inflammatory medications for the treatment of pediatric obstructive sleep apnea

Paediatr Respir Rev. 2020 Apr:34:35-36. doi: 10.1016/j.prrv.2020.02.008. Epub 2020 Mar 10.

Authors

Stefan Kuhle¹, Michael S Urschitz²

Affiliations

¹ Perinatal Epidemiology Research Unit, Departments of Pediatrics and Obstetrics & Gynaecology, Dalhousie University, Halifax, NS, Canada. Electronic address: stefan.kuhle@dal.ca.
² Division of Paediatric Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.

PMID: 32245548
DOI: 10.1016/j.prrv.2020.02.008

No abstract available

Keywords: Child; Corticosteroids; Montelukast; Obstructive sleep apnea; Randomized controlled trial.

Publication types

Review

MeSH terms

Acetates / therapeutic use*
Administration, Intranasal
Administration, Oral
Adolescent
Adrenal Cortex Hormones / therapeutic use*
Anti-Inflammatory Agents / therapeutic use*
Child
Child, Preschool
Cyclopropanes / therapeutic use*
Humans
Infant
Leukotriene Antagonists / therapeutic use*
Quinolines / therapeutic use*
Sleep Apnea, Obstructive / drug therapy*
Sulfides / therapeutic use*
Treatment Outcome

Substances

Acetates
Adrenal Cortex Hormones
Anti-Inflammatory Agents
Cyclopropanes
Leukotriene Antagonists
Quinolines
Sulfides
montelukast